Completed

Phase 2
Age: 21Years - 55Years
All Genders
ID00000318

Buprenorphine Maintenance Dose Schedule and Treatment Setting: Pilot

Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-01-12

202

Participants Needed

1

Research Sites

178 weeks

Total Duration

On this page

Sponsors

N

National Institute on Drug Abuse (NIDA)

Lead Sponsor

Y

Yale University

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to assess optimal dosage of buprenorphine on a thrice weekly schedule in a pilot clinical trial.

CONDITIONS

Official Title

Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1

Who Can Participate

Age: 21Years - 55Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Please contact site for information.

Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Total: 1 location

1

APT Residential Services Division

New Haven, Connecticut, United States, 06519

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

FACTORIAL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here